Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic maintenance of breast cancer cells and metastases through E-cadherin/YAP-dependent pyruvate carboxylase expression.

bioRxiv : the preprint server for biology·2026
Same author

3D "Emboli" Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis.

Cancer research communications·2026
Same author

A Cautionary Tale of <i>Exophiala spinifera</i> Infection in Two Cats: Case Reports and Literature Review.

Case reports in veterinary medicine·2026
Same author

Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation dose.

The Journal of clinical investigation·2025
Same author

A simple liquid 3D cell culture paradigm models oxidative mitochondrial metabolism of epithelial breast cancer cells with relevance for lung metastases.

bioRxiv : the preprint server for biology·2025
Same author

A pilot study evaluating the feasibility of blend electrolysis for hair removal in dogs.

The Canadian veterinary journal = La revue veterinaire canadienne·2025

Related Experiment Video

Updated: May 24, 2026

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities.

Tim Chan1, Timothy C Back, Jeffrey J Subleski

  • 1Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.

Plos One
|March 20, 2012
PubMed
Summary

Systemic interleukin-12 (IL-12) administration enhances liver dendritic cells (DC) function, increasing their T cell activation capabilities. This finding is crucial for developing IL-12 immunotherapies against liver cancers and infections.

More Related Videos

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

Related Experiment Videos

Last Updated: May 24, 2026

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

Area of Science:

  • Immunology
  • Hepatology
  • Cancer Research

Background:

  • The liver possesses a unique immunosuppressive microenvironment maintained by tolerogenic dendritic cells (DC).
  • Systemic interleukin-12 (IL-12) shows promise in cancer treatment, but its impact on hepatic DC is not fully understood.

Purpose of the Study:

  • To investigate the effects of systemic IL-12 administration on hepatic dendritic cells (DC).
  • To assess the functional maturation and T cell stimulatory capacity of IL-12-treated hepatic DC.

Main Methods:

  • Systemic IL-12 administration in mice.
  • Analysis of hepatic DC subsets (conventional and plasmacytoid) via flow cytometry.
  • Assessment of DC phenotype, function, and cytokine production (including IL-12) after toll-like receptor (TLR) agonist co-stimulation.
  • Evaluation of T cell proliferation and activation in the RENCA renal cell carcinoma mouse model.

Main Results:

  • Systemic IL-12 increased conventional hepatic DC by 2-3 fold, without affecting plasmacytoid DC.
  • Hepatic DC exhibited enhanced maturation, resembling splenic DC function but with distinct IL-12 production profiles.
  • IL-12 treatment improved hepatic DC's T cell proliferative capacity.
  • Increased hepatic T cell activation and interferon-gamma (IFNγ) expression were observed in the RENCA model.

Conclusions:

  • Systemic IL-12 administration can overcome the liver's immunosuppressive environment by maturing hepatic DC.
  • Enhanced hepatic DC function holds significant implications for designing IL-12-based immunotherapies for hepatic malignancies and infections.